7 million men and women in the UK are currently living with cardiovascular disease and as such heart and lung disease remain two of the biggest killers in the UK. The HLRI will look to help those people as it will be home to over 380 scientists and state-of-the-art laboratories in genomics, population sciences, research into cellular mechanisms of disease and translational science. It will also include a special ten bed facility where the first-in-patient studies can be conducted.

The HLRI will bring together the highest concentration of heart and lung researchers from academia, healthcare and industry in Europe, meaning new treatments and trials for our patients. In the past pioneering medicine and innovative surgical advances supported by Royal Papworth Charity have not only transformed the lives of hundreds of thousands of patients but also helped shape cardiothoracic medicine internationally.